HIV-1病毒血症与280万人中的癌症风险:南非HIV癌症匹配研究
该研究基于南非HIV癌症匹配研究2004至2014年实验室与癌症登记数据,纳入2770200例HIV感染者与10175例新发癌症,采用Cox比例风险模型分析HIV-1病毒血症与癌症发病风险的关系。完全调整模型显示,HIV-1病毒血症与卡波西肉瘤、白血病、非霍奇金淋巴瘤、结膜癌和结直肠癌风险升高相关,其他癌种关联较弱或无关联。
要点
- 完全调整模型下,HIV-1 RNA每增加1 Log10 copies/mL,卡波西肉瘤HR为1.38(95%CI 1.35-1.42)。
- 白血病HR为1.28(95%CI 1.13-1.45),非霍奇金淋巴瘤HR为1.24(95%CI 1.19-1.29)。
- 结膜癌HR为1.19(95%CI 1.11-1.25),结直肠癌HR为1.11(95%CI 1.02-1.21)。
核心结论
- 研究结果强调南非HIV感染者持续病毒抑制对癌症预防的重要性。
研究设计与样本
- 基于南非HIV癌症匹配研究,分析2004至2014年国家卫生实验室服务实验室检测数据与国家癌症登记处癌症记录。
- 纳入2770200例HIV感染者,共10175例新发癌症。
- 采用Cox比例风险模型估计癌症发病率风险比(HR),以时间更新Log10 HIV-1 RNA病毒载量 copies/mL每单位增加为暴露。
- 建立部分调整模型(性别、年龄、日历年)和完全调整模型(额外包括时间更新CD4计数)。
主要发现
- 最常见癌症为宫颈癌(N=2481)、卡波西肉瘤(N=1902)、乳腺癌(N=1063)和非霍奇金淋巴瘤(N=863)。
- 部分调整和完全调整后,HIV-1病毒血症与癌症风险的HR发生变化,感染相关癌症 generally attenuated,感染无关癌症 tended to increase。
- 完全调整模型中,HIV-1病毒血症与卡波西肉瘤风险升高相关(HR 1.38;95%CI 1.35-1.42)。
- 完全调整模型中,HIV-1病毒血症与白血病(HR 1.28;95%CI 1.13-1.45)、非霍奇金淋巴瘤(HR 1.24;95%CI 1.19-1.29)、结膜癌(HR 1.19;95%CI 1.11-1.25)和结直肠癌(HR 1.11;95%CI 1.02-1.21)风险升高相关。
- 与其他癌症类型的关联较弱或无关联。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Most research on human immunodeficiency virus-1 (HIV-1) viremia and cancer risk is from high-income countries. We evaluated the association between HIV-1 viremia and the risk of various cancer types among people with HIV (PWH) in South Africa. METHODS: We analyzed data from the South African HIV Cancer Match study, based on laboratory measurements from the National Health Laboratory Service and cancer records from the National Cancer Registry from 2004 to 2014. Using Cox proportional hazards models, we estimated hazard ratios (HR) for cancer incidence per unit increase in time-updated Log10 HIV-1 RNA viral load copies/mL. We created partially adjusted (sex, age, calendar year) and fully adjusted models (additionally including time-updated CD4 count). RESULTS: We included 2 770 200 PWH with 10 175 incident cancers; most common were cervical cancer (N = 2481), Kaposi sarcoma (N = 1902), breast cancer (N = 1063), and non-Hodgkin lymphoma (N = 863). Hazard ratios for the association of HIV-1 viremia and cancer risk changed after partial and full adjustment and were generally attenuated for infection-related cancers but tended to increase for infection-unrelated cancers. In the fully adjusted model, HIV-1 viremia was associated with an increased risk of Kaposi sarcoma (HR per unit increase in Log10 HIV-1 RNA viral load: 1.38; 95% confidence interval [CI], 1.35-1.42), leukemia (HR: 1.28; 95% CI, 1.13-1.45), non-Hodgkin lymphoma (HR: 1.24; 95% CI, 1.19-1.29), conjunctival cancer (HR: 1.19; 95% CI, 1.11-1.25), and colorectal cancer (HR: 1.11; 95% CI, 1.02-1.21). Associations with other cancer types were weaker or absent. CONCLUSIONS: Our findings underline the importance of sustained viral suppression for cancer prevention among PWH in South Africa.
引用
- Ruffieux Y, Mwansa-Kambafwile J, Metekoua C, et al. HIV-1 Viremia and Cancer Risk in 2.8 Million People: The South African HIV Cancer Match Study. Clin Infect Dis. 2025. PMID: 39736138. doi:10.1093/cid/ciae652
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。